Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Change in Accured Expenses (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Change in Accured Expenses for 6 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 349.89% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28000.0 through Dec 2025, up 100.72% year-over-year, with the annual reading at $28000.0 for FY2025, 100.72% up from the prior year.
  • Change in Accured Expenses hit $1.1 million in Q4 2025 for Rapid Micro Biosystems, up from $599000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $2.9 million in Q4 2023 to a low of -$3.9 million in Q1 2022.
  • Historically, Change in Accured Expenses has averaged -$144150.0 across 5 years, with a median of -$165500.0 in 2021.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 396.8% in 2022 and later soared 28860.0% in 2023.
  • Year by year, Change in Accured Expenses stood at -$341000.0 in 2021, then surged by 102.93% to $10000.0 in 2022, then skyrocketed by 28860.0% to $2.9 million in 2023, then crashed by 115.16% to -$439000.0 in 2024, then skyrocketed by 349.89% to $1.1 million in 2025.
  • Business Quant data shows Change in Accured Expenses for RPID at $1.1 million in Q4 2025, $599000.0 in Q3 2025, and $335000.0 in Q2 2025.